The global pandemic is pushing the industry to quickly explore how a decentralized approach to clinical research can minimize disruption to on-going trials and improve future trials. Providing patients with innovative and easy-to-use solutions - built on a secure and scalable cloud technology platform - are key to conducting successful virtual trials.

In this webinar you will hear from technology company uMotif on how they collaborate with pharma companies undertaking virtual and decentralized trials. Hear how new patient populations can be reached using cloud-based technology and learn what types of research data can be collected from different devices and wearables.

From this webinar you will learn:

• How a patient-centric approach is paramount to successfully conducting virtual trials
• The benefits sponsor organisations can expect to achieve from adopting a decentralized approach
• How secure and scalable cloud-based technology is vital to power virtual trials
• Examples of innovative ways virtual clinical trials are being deployed, such as dry blood spot sampling

Featured Speaker

Bruce Hellman

CEO and Co-Founder
uMotif

Bruce is CEO and Co-Founder at uMotif. He and his team are on a mission to put patients at the centre of research by designing and building data capture solutions people love to use.

Bruce is recognized in the 2019 PharmaVOICE 100 as one of the most innovative entrepreneurs in life sciences and has also been nominated as one of Computer Weekly's UKtech50 Rising Stars, won the Cisco BIG awards, and was nominated by Real Business magazine as one of the '30 to watch in mobile'.

Date:  Wednesday, August 19, 2020
Time:  11am ET / 8am PT
Duration:  1 Hour

Register now for this webinar